News | May 05, 2023
Merck plans bioprocessing center in South Korea
The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia-Pacific.
The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia-Pacific.
The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth
With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette’s existing pharma innovation centers in France and Singapore
To enable company to be future-ready by tapping potential in CDMO space
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
The Development Center with its state-of-the art laboratories and flexible pilot capacities is set to become Siegfried's global research and development hub for its Drug Products sites, strengthening the global network
MVUs will provide diagnosis treatment, vaccination, artificial insemination, minor surgical interventions, audio-visual aids and extension services to farmers/animal owners at their doorstep in far flung areas.
Centre and states need to work in tandem and in a collaborative spirit as was done during the previous surges for COVID-19 prevention and management
The new center will focus on supporting the clinical trials clients who are developing cell and gene therapies
New Lexington, Massachusetts facility to provide customer education and collaboration opportunities
Subscribe To Our Newsletter & Stay Updated
